MOTCO’s Bio-Rad Laboratories Class A BIO Stock Holding History

MOTCO’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2	Closed	-$1K	–	597
2020 Q4	$1K	Buy	+2	New	+$1.14K	﹤0.01%	717
2019 Q3	–	Sell	-80	Closed	-$25K	–	544
2019 Q2	$25K	Buy	+80	New	+$24K	﹤0.01%	451

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

MOTCO's BIO Position: Q1 2021 in Review

MOTCO sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2021, closing a stake of 2 shares — an estimated $1K sold.

MOTCO first reported a position in BIO in Q2 2019 and held it in 2 quarters. The position peaked at $25K in Q2 2019. 491 funds tracked by Wall St. Rank hold BIO as of Q1 2021.

MOTCO reported no remaining Bio-Rad Laboratories Class A position as of Q1 2021 after selling out during the quarter.
MOTCO sold 2 Bio-Rad Laboratories Class A shares in Q1 2021, an estimated $1K.
MOTCO first reported a position in Bio-Rad Laboratories Class A in Q2 2019 and held it in 2 quarters.
MOTCO's Bio-Rad Laboratories Class A position peaked at $25K in Q2 2019.
491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2021.

Based on MOTCO's 13F filing for Q1 2021, filed 16 Apr 2021.